Defense Nuclear & Microreactor Cluster Report
4/1/26
SEQH CAPITAL RESEARCH – TEAR SHEET
DEFENSE NUCLEAR & MICROREACTOR CLUSTER
CORE SETUP
The U.S. defense nuclear ecosystem is moving on a fundamentally faster track than commercial SMRs, with DOE authorization pathways, EO 14299 mandates, and sole‑source defense contracts pulling first power into the 2026–2028 window vs 2030–2034 for most commercial designs.
This report defines a focused “defense nuclear cluster” of investable names around that trend: BWXT (anchor contractor), OKLO (advanced reactor + defense optionality), NNE (HALEU logistics), ASPI (laser enrichment optionality), plus key private programs at Radiant and Westinghouse/eVinci.
WHY DEFENSE NUCLEAR IS DIFFERENT
Commercial SMR programs are gated by 3–5 year NRC licensing cycles, site‑specific approvals, and utility offtake, keeping most large deployments out beyond 2030.
Defense and national‑lab deployments bypass much of that bottleneck via DOE authorization (not NRC), Other Transaction Authority contracts, and a hard presidential mandate (EO 14299) requiring advanced nuclear at U.S. military installations by September 2028.
Flagship federal programs, Project Pele, NNSA’s $1.5B DUECE enrichment pilot, the DOE Reactor Pilot Program (criticality by July 4, 2026), INL’s DOME microreactor test facility, and the DIU ANPI initiative—create funded, deadline‑driven demand that shows up in real backlogs and near‑term revenue rather than just long‑dated PPAs.
THE INVESTABLE PERIMETER – KEY NAMES
BWXT: “Defense nuclear anchor” with ~$17.9B market cap, ~$7.3B backlog (+50% YoY), sole‑source positions in naval fuel, NNSA DUECE enrichment, TRISO fuel, and as Project Pele prime; 2025 revenue +18% and EPS +20%, 2026 guidance for ~$3.75B revenue and ~$4.55–4.70 EPS.
OKLO: Marketed as an advanced reactor/SMR developer but with underpriced defense optionality via DOE RPP (Aurora at INL), Eielson AFB microreactor process, and Atomic Alchemy’s Groves isotope test reactor; all with 2026 criticality targets that can simultaneously de‑risk military and commercial pipelines.
NANO Nuclear (NNE): Pre‑revenue HALEU logistics name building the first NRC‑certified HALEU transport system (exclusive INL license, GNS collaboration), a required link for every HALEU‑fueled microreactor from Pele to Radiant, Oklo, and eVinci.
ASP Isotopes (ASPI): Small‑cap laser‑enrichment optionality via Quantum Leap Energy, with MOUs spanning U.S. operators, Fermi America, and Necsa for HALEU/LEU+ and isotopes; higher risk but potentially transformational for HALEU economics if projects advance.
Private nodes: Radiant’s Kaleidos microreactor and Westinghouse eVinci are first up at INL’s DOME in Spring 2026; Westinghouse exposure is reachable indirectly through Cameco’s stake.
CATALYSTS & RISKS
Near‑term catalysts: 2026 DOME tests (Radiant, eVinci), July 4, 2026 DOE RPP criticality targets (Oklo Aurora and Groves isotope reactor), BWXT naval fuel deliverables and DUECE licensing ramp, NNE’s NRC engagement, and 2027 Pele prototype delivery; all culminating in the EO 14299 September 2028 deployment deadline.
Key risks: potential slippage or dilution of the EO 14299 mandate, HALEU production delays, the need to eventually clear NRC hurdles for commercialization, valuation risk in pre‑revenue names (OKLO, NNE, ASPI), and BWXT’s concentration as the single point of failure across several core contracts.
WHAT PAID MEMBERS GET IN THE FULL REPORT
Upgrade to unlock the full defense nuclear cluster analysis, including:
Detailed defense vs commercial SMR timeline comparison, plus program‑by‑program coverage of Pele, DUECE, RPP, DOME, and ANPI with associated funding levels.
Full company profiles for BWXT, OKLO, NNE, and ASPI, including backlog, contract breakdowns, financials/guidance, and SEQH’s cluster‑role view for each.
Enabling‑infrastructure section on HALEU enrichment and transport, mapping how Centrus, NNE, ASPI, and BWXT’s enrichment work underpin defense deployments.
A catalyst calendar through 2028 and a risk matrix that tie specific federal milestones and deadlines directly to equity re‑rating windows within the cluster.
For the full mapping from defense programs to specific equities, and the catalyst and risk work behind treating defense nuclear as a separate, faster timeline trade, consider upgrading to the paid tier for the complete Defense Nuclear & Microreactor Cluster report and future updates.
